Warby Parker Inc. Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
Warby Parker Inc. (WRBY) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price of $3.83 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice · last filed 2026-08-06
- Warby Parker Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- Warby Parker Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2025-03-31 was $11.35, a 11.60% decline year-over-year.
- Warby Parker Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2024-03-31 was $12.84, a 1.46% decline year-over-year.
- Warby Parker Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2023-03-31 was $13.03, a 38.32% increase year-over-year.
- Warby Parker Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2025 was $7.35, a 42.85% decline from fiscal 2024.
- Warby Parker Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2024 was $12.86, a 76.16% increase from fiscal 2023.
- Warby Parker Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2023 was $7.30, a 35.74% decline from fiscal 2022.
- Warby Parker Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2022 was $11.36, a 71.60% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.83 10-Q · filed 2026-08-06 | |||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | $7.35 10-K · filed 2026-02-26 | |||
| 2025-09-30 | $8.12 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | $8.90 10-Q · filed 2025-08-08 | |||
| 2025-03-31 | $11.35 10-Q · filed 2025-05-08 | |||
| 2024-12-31 | $12.86 10-K · filed 2025-02-27 | |||
| 2024-09-30 | $11.78 10-Q · filed 2024-11-07 | |||
| 2024-06-30 | $11.57 10-Q · filed 2024-08-08 | |||
| 2024-03-31 | $12.84 10-Q · filed 2024-05-09 | |||
| 2023-12-31 | $7.30 10-K · filed 2024-02-29 | |||
| 2023-09-30 | $6.47 10-Q · filed 2023-11-08 | |||
| 2023-06-30 | $5.68 10-Q · filed 2023-08-09 | |||
| 2023-03-31 | $13.03 10-Q · filed 2023-05-09 | |||
| 2022-12-31 | $11.36 10-K · filed 2023-02-28 | |||
| 2022-09-30 | $11.44 10-Q · filed 2022-11-10 | |||
| 2022-06-30 | $10.88 10-Q · filed 2022-08-11 | |||
| 2022-03-31 | $9.42 10-Q · filed 2022-05-16 | |||
| 2021-12-31 | $6.62 10-K · filed 2022-03-18 | |||
| 2021-09-30 | $7.47 10-Q · filed 2021-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| RxSight, Inc. (RXST) | United States | $0.197B | |
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |